Safety profile of triple ICS/LABA/LAMA FDC in the treatment of asthma: a meta-analysis

被引：0
|
作者：
Calzetta, L. [1 ]
Cavalli, F. [2 ]
Chetta, A. [1 ]
Cazzola, M. [2 ]
Rogliani, P. [2 ]
机构：
[1] Univ Parma, Parma, Italy
[2] Univ Roma Tor Vergata, Rome, Italy
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
Asthma; Pharmacology; Treatments;
D O I：
10.1183/13993003.congress-2022.294
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
294
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Late Breaking Abstract - Impact of ICS/LABA and LABA/LAMA FDCs on lung function and exacerbation of COPD: a network meta-analysis
    Di Marco, Fabiano
    Calzetta, Luigino
    Rogliani, Paola
    Blasi, Francesco
    Centanni, Stefano
    Micheletto, Claudio
    Rossi, Andrea
    Cazzola, Mario
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [22] Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
    Vanfleteren, Lowie E. G. W.
    Ullman, Anders
    Nordenson, Anita
    Andersson, Anders
    Andelid, Kristina
    Fabbri, Leonardo M.
    ERJ OPEN RESEARCH, 2019, 5 (01)
  • [23] Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis
    Koarai, Akira
    Sugiura, Hisatoshi
    Yamada, Mitsuhiro
    Ichikawa, Tomohiro
    Fujino, Naoya
    Kawayama, Tomotaka
    Ichinose, Masakazu
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [24] Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis
    Akira Koarai
    Hisatoshi Sugiura
    Mitsuhiro Yamada
    Tomohiro Ichikawa
    Naoya Fujino
    Tomotaka Kawayama
    Masakazu Ichinose
    BMC Pulmonary Medicine, 20
  • [25] Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
    Koarai, Akira
    Yamada, Mitsuhiro
    Ichikawa, Tomohiro
    Fujino, Naoya
    Kawayama, Tomotaka
    Sugiura, Hisatoshi
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [26] Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
    Akira Koarai
    Mitsuhiro Yamada
    Tomohiro Ichikawa
    Naoya Fujino
    Tomotaka Kawayama
    Hisatoshi Sugiura
    Respiratory Research, 22
  • [27] Single Inhaler Triple-Therapy (ICS/LAMA/LABA) Versus Dual-Therapy (ICS/LABA or LAMA/LABA) in Patients with COPD at Risk of Exacerbations: Efficacy and Safety Results of the Phase III IMPACT Trial
    Lipson, D. A.
    Barnhart, F.
    Brealey, N.
    Day, N. C.
    Brooks, J.
    Criner, G.
    Dransfield, M. T.
    Halpin, D. M.
    Han, M. K.
    Jones, C.
    Kilbride, S.
    Lange, P.
    Lomas, D. A.
    Martinez, F. J.
    Singh, D.
    Tabberer, M.
    Wise, R. A.
    Pascoe, S. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [28] Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework
    Chen, Chun-Yu
    Pan, Sheng-Wei
    Hsu, Chia-Chen
    Liu, Jason J.
    Kumamaru, Hiraku
    Dong, Yaa-Hui
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [29] Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework
    Chun-Yu Chen
    Sheng-Wei Pan
    Chia-Chen Hsu
    Jason J. Liu
    Hiraku Kumamaru
    Yaa-Hui Dong
    Respiratory Research, 24
  • [30] Predictors of treatment response to high-dose ICS/LABA or medium-dose ICS/LABA plus LAMA in asthma patients - TAILOR study
    Verhamme, K. M.
    De Ridder, M.
    Rijnbeek, P.
    Mosseveld, M.
    Pedersen, L.
    Marconi, E.
    Lapi, F.
    Tan, C.
    Delmestri, A.
    Prieto-Alhambra, D.
    Nudo, E.
    Brusselle, G.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
12345